Molecular challenges of neuroendocrine tumors (Review)

Parthik Patel, Karina Galoian

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Neuroendocrine tumors (NETs) are a very heterogeneous group that are thought to originate from the cells of the endocrine and nervous systems. These tumors develop in a number of organs, predominantly in the gastrointestinal and pulmonary systems. Clinical detection and diagnosis are reliable at the late stages when metastatic spread has occurred. However, traditional conventional therapies such as radiation and chemotherapy are not effective. In the majority of cases even surgical resection at that stage is unlikely to produce promising reusults. NETs present a serious clinical challenge, as the survival rates remain low, and as these rare tumors are very difficult to study, novel approaches and therapies are required. This review will highlight the important points of accumulated knowledge covering the molecular aspects of the role of neuroendocrine cells, hormonal peptides, the reasons for ectopic hormone production in NET, neuropeptides and epigenetic regulation as well as the other challenging questions that require further understanding.

Original languageEnglish (US)
Pages (from-to)2715-2725
Number of pages11
JournalOncology Letters
Volume15
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Neuroendocrine Tumors
Ectopic Hormones
Neuroendocrine Cells
Endocrine System
Neuropeptides
Epigenomics
Nervous System
Neoplasms
Radiation
Drug Therapy
Lung
Peptides
Therapeutics

Keywords

  • Epigenetics
  • Hormones
  • Mammalian target of rapamycin
  • Neuroendocrine tumors
  • Neuropeptides
  • Signal transduction pathways

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Molecular challenges of neuroendocrine tumors (Review). / Patel, Parthik; Galoian, Karina.

In: Oncology Letters, Vol. 15, No. 3, 01.03.2018, p. 2715-2725.

Research output: Contribution to journalReview article

Patel, Parthik ; Galoian, Karina. / Molecular challenges of neuroendocrine tumors (Review). In: Oncology Letters. 2018 ; Vol. 15, No. 3. pp. 2715-2725.
@article{43c14ef32b61444883ceb4e1bd4dfc39,
title = "Molecular challenges of neuroendocrine tumors (Review)",
abstract = "Neuroendocrine tumors (NETs) are a very heterogeneous group that are thought to originate from the cells of the endocrine and nervous systems. These tumors develop in a number of organs, predominantly in the gastrointestinal and pulmonary systems. Clinical detection and diagnosis are reliable at the late stages when metastatic spread has occurred. However, traditional conventional therapies such as radiation and chemotherapy are not effective. In the majority of cases even surgical resection at that stage is unlikely to produce promising reusults. NETs present a serious clinical challenge, as the survival rates remain low, and as these rare tumors are very difficult to study, novel approaches and therapies are required. This review will highlight the important points of accumulated knowledge covering the molecular aspects of the role of neuroendocrine cells, hormonal peptides, the reasons for ectopic hormone production in NET, neuropeptides and epigenetic regulation as well as the other challenging questions that require further understanding.",
keywords = "Epigenetics, Hormones, Mammalian target of rapamycin, Neuroendocrine tumors, Neuropeptides, Signal transduction pathways",
author = "Parthik Patel and Karina Galoian",
year = "2018",
month = "3",
day = "1",
doi = "10.3892/ol.2017.7680",
language = "English (US)",
volume = "15",
pages = "2715--2725",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - Molecular challenges of neuroendocrine tumors (Review)

AU - Patel, Parthik

AU - Galoian, Karina

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Neuroendocrine tumors (NETs) are a very heterogeneous group that are thought to originate from the cells of the endocrine and nervous systems. These tumors develop in a number of organs, predominantly in the gastrointestinal and pulmonary systems. Clinical detection and diagnosis are reliable at the late stages when metastatic spread has occurred. However, traditional conventional therapies such as radiation and chemotherapy are not effective. In the majority of cases even surgical resection at that stage is unlikely to produce promising reusults. NETs present a serious clinical challenge, as the survival rates remain low, and as these rare tumors are very difficult to study, novel approaches and therapies are required. This review will highlight the important points of accumulated knowledge covering the molecular aspects of the role of neuroendocrine cells, hormonal peptides, the reasons for ectopic hormone production in NET, neuropeptides and epigenetic regulation as well as the other challenging questions that require further understanding.

AB - Neuroendocrine tumors (NETs) are a very heterogeneous group that are thought to originate from the cells of the endocrine and nervous systems. These tumors develop in a number of organs, predominantly in the gastrointestinal and pulmonary systems. Clinical detection and diagnosis are reliable at the late stages when metastatic spread has occurred. However, traditional conventional therapies such as radiation and chemotherapy are not effective. In the majority of cases even surgical resection at that stage is unlikely to produce promising reusults. NETs present a serious clinical challenge, as the survival rates remain low, and as these rare tumors are very difficult to study, novel approaches and therapies are required. This review will highlight the important points of accumulated knowledge covering the molecular aspects of the role of neuroendocrine cells, hormonal peptides, the reasons for ectopic hormone production in NET, neuropeptides and epigenetic regulation as well as the other challenging questions that require further understanding.

KW - Epigenetics

KW - Hormones

KW - Mammalian target of rapamycin

KW - Neuroendocrine tumors

KW - Neuropeptides

KW - Signal transduction pathways

UR - http://www.scopus.com/inward/record.url?scp=85040825620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040825620&partnerID=8YFLogxK

U2 - 10.3892/ol.2017.7680

DO - 10.3892/ol.2017.7680

M3 - Review article

AN - SCOPUS:85040825620

VL - 15

SP - 2715

EP - 2725

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 3

ER -